Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 23, No 25 (September 1), 2005: pp. 6083-6096
© 2005 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.09.548

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Savard, J.
Right arrow Articles by Morin, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Savard, J.
Right arrow Articles by Morin, C. M.

Randomized Study on the Efficacy of Cognitive-Behavioral Therapy for Insomnia Secondary to Breast Cancer, Part I: Sleep and Psychological Effects

Josée Savard, Sébastien Simard, Hans Ivers, Charles M. Morin

From the Laval University Cancer Research Center; and School of Psychology, Université Laval, Québec, Québec, Canada

Address reprint requests to Josée Savard, PhD, Laval University Cancer Research Center, 11 Côte du Palais, Québec, Québec, G1R 2J6 Canada; e-mail: josee.savard{at}psy.ulaval.ca

PURPOSE: Chronic insomnia is highly prevalent in cancer patients. Cognitive-behavioral therapy (CBT) is considered the treatment of choice for chronic primary insomnia. However, no randomized controlled study has been conducted on its efficacy for insomnia secondary to cancer. Using a randomized controlled design, this study conducted among breast cancer survivors evaluated the effect of CBT on sleep, assessed both subjectively and objectively, and on hypnotic medication use, psychological distress, and quality of life.

PATIENTS AND METHODS: Fifty-seven women with insomnia caused or aggravated by breast cancer were randomly assigned to CBT (n = 27) or a waiting-list control condition (n = 30). The treatment consisted of eight weekly sessions administered in a group and combined the use of stimulus control, sleep restriction, cognitive therapy, sleep hygiene, and fatigue management. Follow-up evaluations were carried out 3, 6, and 12 months after the treatment.

RESULTS: Participants who received the insomnia treatment had significantly better subjective sleep indices (daily sleep diary, Insomnia Severity Index), a lower frequency of medicated nights, lower levels of depression and anxiety, and greater global quality of life at post-treatment compared with participants of the control group after their waiting period. Results were more equivocal on polysomnographic indices. Therapeutic effects were well maintained up to 12 months after the intervention and generally were clinically significant.

CONCLUSION: This study supports the efficacy of CBT for insomnia secondary to breast cancer.

Supported in part by an operating grant (MT-14039) and salary support from the Canadian Institutes of Health Research.

Results of this study have been reported in part at the 16th Annual Meeting of the Associated Professional Sleep Societies, Seattle, WA, June 2002; the 62nd Annual Convention of the Canadian Psychological Association, Québec, Québec, Canada, June 2001; the 2nd Scientific Conference on Reasons for Hope: New Developments in Breast Cancer Research, Québec, Québec, Canada, May 2001; the 6th World Congress of Psycho-Oncology, Banff, Alberta, Canada, April 2003; and the 6th International Congress of Behavioral Medicine, Brisbane, Australia, November 2000.

Authors' disclosures of potential conflicts of interest are found at the end of this article.




This article has been cited by other articles:


Home page
JCOHome page
C. A. Espie, L. Fleming, J. Cassidy, L. Samuel, L. M. Taylor, C. A. White, N. J. Douglas, H. M. Engleman, H.-L. Kelly, and J. Paul
Randomized Controlled Clinical Effectiveness Trial of Cognitive Behavior Therapy Compared With Treatment As Usual for Persistent Insomnia in Patients With Cancer
J. Clin. Oncol., October 1, 2008; 26(28): 4651 - 4658.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. E. Bower
Behavioral Symptoms in Patients With Breast Cancer and Survivors
J. Clin. Oncol., February 10, 2008; 26(5): 768 - 777.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
K. M. Mustian, G. R. Morrow, J. K. Carroll, C. D. Figueroa-Moseley, P. Jean-Pierre, and G. C. Williams
Integrative Nonpharmacologic Behavioral Interventions for the Management of Cancer-Related Fatigue
Oncologist, May 1, 2007; 12(suppl_1): 52 - 67.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. Savard, S. Simard, H. Ivers, and C. M. Morin
Randomized Study on the Efficacy of Cognitive-Behavioral Therapy for Insomnia Secondary to Breast Cancer, Part II: Immunologic Effects
J. Clin. Oncol., September 1, 2005; 23(25): 6097 - 6106.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2005 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online